Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
- PMID: 2911023
- DOI: 10.1111/j.1471-4159.1989.tb09133.x
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
Abstract
Polyunsaturated fatty acid (PUFA) levels (an index of the amount of substrate available for lipid peroxidation) were measured in several brain regions from patients who died with Parkinson's disease and age-matched control human postmortem brains. PUFA levels were reduced in parkinsonian substantia nigra compared to other brain regions and to control tissue. However, basal malondialdehyde (MDA; an intermediate in the lipid peroxidation process) levels were increased in parkinsonian nigra compared with other parkinsonian brain regions and control tissue. Expressing basal MDA levels in terms of PUFA content, the difference between parkinsonian and control substantia nigra was even more pronounced. Stimulating MDA production by incubating tissue with FeSO4 plus ascorbic acid, FeSO4 plus H2O2, or air alone produced lower MDA levels in the parkinsonian substantia nigra, probably reflecting the lower PUFA content. These results may indicate that an increased level of lipid peroxidation continues to occur in the parkinsonian nigra up to the time of death, perhaps because of continued exposure to excess free radicals derived from some endogenous or exogenous neurotoxic species.
Similar articles
-
Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.Neurochem Res. 1993 Oct;18(10):1101-6. doi: 10.1007/BF00966691. Neurochem Res. 1993. PMID: 8255359
-
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.J Neurochem. 1991 Mar;56(3):978-82. doi: 10.1111/j.1471-4159.1991.tb02017.x. J Neurochem. 1991. PMID: 1704426
-
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.J Neurochem. 1989 Jun;52(6):1830-6. doi: 10.1111/j.1471-4159.1989.tb07264.x. J Neurochem. 1989. PMID: 2723638
-
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S82-7. doi: 10.1002/ana.410320714. Ann Neurol. 1992. PMID: 1510385 Review.
-
Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).Ann N Y Acad Sci. 1994 Nov 17;738:214-21. doi: 10.1111/j.1749-6632.1994.tb21806.x. Ann N Y Acad Sci. 1994. PMID: 7832430 Review.
Cited by
-
Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Neurotox Res. 2013 Apr;23(3):267-300. doi: 10.1007/s12640-012-9337-4. Epub 2012 Jun 28. Neurotox Res. 2013. PMID: 22739839 Review.
-
Combined elemental and biomolecular mass spectrometry imaging for probing the inventory of tissue at a micrometer scale.Anal Chem. 2012 Apr 3;84(7):3170-8. doi: 10.1021/ac203112c. Epub 2012 Mar 20. Anal Chem. 2012. PMID: 22413784 Free PMC article.
-
The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms.Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):306-17. doi: 10.1177/1533317513488919. Epub 2013 May 21. Am J Alzheimers Dis Other Demen. 2013. PMID: 23695225 Free PMC article. Review.
-
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.Neurotoxicology. 2024 Jul;103:266-287. doi: 10.1016/j.neuro.2024.06.016. Epub 2024 Jul 2. Neurotoxicology. 2024. PMID: 38964509 Review.
-
Parkinson's disease: pathological mechanisms and actions of piribedil.J Neurol. 1992;239 Suppl 1:S2-8. doi: 10.1007/BF00819559. J Neurol. 1992. PMID: 1634907 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
